Cabozantinib – Cabozanib 40 Mg

Cabozanib™ is a quality-assured generic of Cabometyx® which is used to treat advanced renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC) in patients who were previously treated with sorafenib. It’s also used to treat differentiated thyroid cancer (DTC) that has progressed after VEGFR-targeted treatment in patients who can no longer be treated with radioactive iodine.